Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.925
-0.035 (-1.79%)
Jan 29, 2026, 3:14 PM EST - Market open
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $74.04 million as of January 29, 2026. Its market cap has increased by 27.46% in one year.
Market Cap
74.04M
Enterprise Value
67.72M
1-Year Change
27.46%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $74.04M, a decrease of -40.60%. That is a compound annual growth rate of -10.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 75.39M | -39.13% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 82.62M |
| ALX Oncology Holdings | 81.33M |
| OKYO Pharma | 80.11M |
| Pelthos Therapeutics | 79.90M |
| PolyPid | 79.85M |
| Equillium | 79.16M |
| ImageneBio | 78.28M |
| Pliant Therapeutics | 78.04M |